Carcinoid syndrome epidemiology and demographics

Carcinoid syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carcinoid Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carcinoid syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carcinoid syndrome epidemiology and demographics
CDC on Carcinoid syndrome epidemiology and demographics
Carcinoid syndrome epidemiology and demographics in the news
Blogs on Carcinoid syndrome epidemiology and demographics
Directions to Hospitals Treating Carcinoid syndrome
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately 15 per 100,000 individuals worldwide. The median age at diagnosis is 61.4 years.

Epidemiology and Demographics

Incidence

• The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide.
• The median age at diagnosis is 60.9 years.
• Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
• Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
• Ovarian carcinoid tumors account for 0.3% of all ovarian tumors and 0.5% of carcinoid tumors.

Age

• Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women.

Gender

• Females are more commonly affected with carcinoid syndrome than males.
• Males are more commonly affected with thymic carcinoid tumor than females The male to female ratio is approximately 3 to 1.